CAREY STEPHEN P. 4
4 · ANI PHARMACEUTICALS INC · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
ANI Pharmaceuticals (ANIP) CFO Stephen Carey Withholds 5,503 Shares for Taxes
What Happened
Stephen P. Carey, Senior Vice President & Chief Financial Officer of ANI Pharmaceuticals, had 5,503 shares withheld on Feb 11, 2026 to satisfy tax withholding related to the vesting of performance stock units. The withheld shares are reported as a disposition at $76.25 per share, for a value of $419,604. This was a tax-withholding event (routine) tied to a prior award, not an open-market sale.
Key Details
- Transaction date and price: Feb 11, 2026 — 5,503 shares withheld at $76.25/share (total $419,604).
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: Shares were withheld for tax purposes under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units granted April 6, 2023.
- Filing timeliness: Form filed Feb 13, 2026 for a Feb 11 transaction; filing appears timely based on standard Section 16 reporting windows.
Context
This was a tax-withholding disposition (transaction code F), a common administrative step when restricted or performance shares vest. Such withholdings are routine and do not necessarily indicate insider sentiment about the company. The underlying award (16,210 PSUs) was previously reported on April 6, 2023.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-02-11$76.25/sh−5,503$419,604→ 175,360 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023.